GSK and adesso Launch DREAM to Improve Global Treatment Adherence

GSK has partnered with IT services provider adesso to develop DREAM (Digital Reminders for Adherence of Medicines and Vaccines), a digital solution designed to help patients stay on track with medication and vaccination schedules. Originally launched in five pilot markets, DREAM now operates in 23 countries, including the UK, Spain, and Italy.

The system delivers personalised, user-friendly reminders to patients, addressing a key healthcare challenge: improving treatment adherence. DREAM was developed with scalability in mind, allowing it to meet regulatory needs across multiple global markets.

GSK praised adesso’s agile, committed approach and technological expertise, which helped bring DREAM to life. The collaboration has been ongoing for 18 months and continues to expand, laying the groundwork for future digital health services.

DREAM exemplifies how digital innovation can support better healthcare outcomes worldwide.